{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:05:41Z","timestamp":1785542741350,"version":"3.56.0"},"reference-count":31,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T00:00:00Z","timestamp":1320710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:p>\n                    Bisphosphonates are used worldwide as a successful treatment for people with osteoporosis, which is the major underlying cause of fractures in postmenopausal women and older adults. These agents are successful at increasing bone mass and bone trabecular thickness, decreasing the risk of fracture, and decreasing bone pain, enabling individuals to have better quality of life. Bisphosphonates are also used to treat multiple myeloma, bone metastasis, and\n                    <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>\n                    aget's disease; however, bisphosphonate treatment may result in negative side effects, including osteonecrosis of the jaw (\n                    <jats:styled-content style=\"fixed-case\">ONJ<\/jats:styled-content>\n                    ).\n                    <jats:styled-content style=\"fixed-case\">ONJ<\/jats:styled-content>\n                    involves necrotic, exposed bone in the jaw, pain, possible secondary infection, swelling, painful lesions, and various dysesthesias, although less\u2010severe cases may be asymptomatic. First\u2010generation bisphosphonates, which do not contain nitrogen, are metabolized into a nonfunctional, cytotoxic analogue of adenosine triphosphate and cause osteoclast death by starvation. Second\u2010generation bisphosphonates are nitrogen\u2010containing agents; these inhibit osteoclast vesicular trafficking, membrane ruffling, morphology, and cytoskeletal arrangement by inhibiting farnesyl diphosphate synthase in the mevalonate pathway. Physicians treating older adults with osteoporosis and cancer should work together with dental practitioners, pharmacists, and other clinicians to inform individuals receiving bisphosphonates of their possible side effects and to suggest precautionary steps that may minimize the risk of osteonecrosis, particularly of the jaw. These include practicing good oral hygiene; scheduling regular dental examinations and cleanings; and cautioning people who are scheduling treatment for periodontal disease, oral and maxillofacial therapy, endodontics, implant placement, restorative dentistry, and prosthodontics. Recommendations for management of people with\n                    <jats:styled-content style=\"fixed-case\">ONJ<\/jats:styled-content>\n                    include an oral rinse, such as chlorhexidine, and antibiotics.\n                  <\/jats:p>","DOI":"10.1111\/j.1532-5415.2011.03713.x","type":"journal-article","created":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T10:33:22Z","timestamp":1320748402000},"page":"2350-2355","source":"Crossref","is-referenced-by-count":59,"title":["Bisphosphonates and Osteonecrosis of the Jaw"],"prefix":"10.1111","volume":"59","author":[{"given":"Jodi","family":"Shannon","sequence":"first","affiliation":[{"name":"College of Dentistry University of Tennessee Memphis Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Shannon","sequence":"additional","affiliation":[{"name":"JL Shannon Dentistry Jonesboro Arkansas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Modelevsky","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial Surgery Jonesboro Arkansas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne A.","family":"Grippo","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences Arkansas State University State University Arkansas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,11,8]]},"reference":[{"key":"e_1_2_10_2_1","unstructured":"American College of Rheumatology.Practice management: Osteoporosis[on\u2010line]. Available athttp:\/\/www.rheumatology.org\/practice\/clinical\/patients\/diseases_and_conditions\/osteoporosis.asp2009 Accessed July 13 2011."},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1563\/1548-1336(2008)34[76:EOOAAO]2.0.CO;2"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2007.10.006"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2007.10.002"},{"key":"e_1_2_10_6_1","unstructured":"American Dental Association.Osteonecrosis of the jaw[on\u2010line]. Available athttp:\/\/www.ada.org\/2995.aspx?currentTab=1(Dentist version) 2008 Accessed July 13 2011."},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2006.0355"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.4065\/83.9.1032"},{"key":"e_1_2_10_9_1","unstructured":"Medscape Medical News.Legal action on jaw necrosis from bisphosphonates[on\u2010line]. Available athttp:\/\/www.medscape.com\/viewarticle\/5382342005 Accessed July 13 2011."},{"key":"e_1_2_10_10_1","unstructured":"National Osteoporosis Foundation.About osteoporosis[on\u2010line]. Available athttp:\/\/www.nof.org2010 Accessed July 13 2011."},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/154405910708601102"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2007.0242"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/ID.0b013e31815fa006"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10593"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/jop.2006.2.1.7"},{"key":"e_1_2_10_16_1","first-page":"1096","article-title":"Bisphosphonate\u2010associated mandibular osteonecrosis","volume":"27","author":"Carniero E","year":"2006","journal-title":"Am J Neuroradiol"},{"key":"e_1_2_10_17_1","unstructured":"American Association of Oral and Maxillofacial Surgeons.Position paper on bisphosphonate\u2010related osteonecrosis of the jaw 2009 update[on\u2010line]. Available athttp:\/\/www.aaoms.org\/docs\/position_papers\/bronj_update.pdfAccessed July 13 2011."},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0843"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0850"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-4272"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.SABCS-2151"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2008.0016"},{"key":"e_1_2_10_23_1","unstructured":"National Institute of Dental and Craniofacial Research.Bisphosphonate\u2010associated osteonecrosis of the jaw: Pathophysiology and epidemiology[on\u2010line]. Available athttp:\/\/www.nidcr.nih.gov\/GrantsAndFunding\/See_Funding_Opportunities_Sorted_By\/ConceptClearance\/CurrentCC\/Bisphosphonate.htm2010 Accessed July 13 2011."},{"key":"e_1_2_10_24_1","unstructured":"RussellLA.Bisphosphonates and osteonecrosis of the jaw. Hospital for Special Surgery[on\u2010line]. Available athttp:\/\/www.hss.edu\/professional-conditions_new-concerns-bisphosphonates.asp2006 Accessed July 13 2011."},{"key":"e_1_2_10_25_1","unstructured":"GarvinJ.ADA resources answer bisphosphonate questions; \u201cResearch and treatment experience is moving quickly.\u201d Am Dent Assoc News[on\u2010line]. Available athttp:\/\/www.ada.org\/news\/2254.aspx2008 Accessed July 13 2011."},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2050"},{"key":"e_1_2_10_27_1","unstructured":"ClarkeB KokaS.Bisphosphonate\u2010associated osteonecrosis of the jaw. American College of Rheumatology Hotline[on\u2010line]. Available athttp:\/\/www.rheumatology.org\/publications\/hotline\/0606onj.asp2006 Accessed July 13 2011."},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2009.0019"},{"key":"e_1_2_10_29_1","unstructured":"National Institutes of Health Department of Health and Human Services.Osteonecrosis[on\u2010line]. Available athttp:\/\/www.niams.nih.gov\/health_info\/osteonecrosis\/default.asp2009 Accessed July 13 2011."},{"key":"e_1_2_10_30_1","unstructured":"Google search:Lawyers osteonecrosis of the jaw bisphosphonates[on\u2010line]. Available athttp:\/\/www.google.com\/search?hl=en&&sa=X&ei=y7ArTLPvAsipnQfohrHfCQ&ved=0CCQQBSgA&q=lawyers+osteonecrosis+of+the+jaw+bisphosphonates&spell=1Accessed July 13 2011."},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2005.0109"},{"key":"e_1_2_10_32_1","unstructured":"DamatoK GralowJ HoffAet\u00a0al.Expert panel recommendations for the prevention diagnosis and treatment of osteonecrosis of the jaws. Novartis Pharmaceuticals Corporation[on\u2010line]. Available athttp:\/\/www.fda.gov\/ohrms\/dockets\/ac\/05\/briefing\/2005-4095B2_02_12-Novartis-Zometa-App-11.pdf2005 Accessed July 13 2011."}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1532-5415.2011.03713.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.2011.03713.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:16:05Z","timestamp":1762193765000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1532-5415.2011.03713.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,8]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["10.1111\/j.1532-5415.2011.03713.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03713.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,8]]}}}